Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy.
Wong
A L
AL
Department of Haematology-Oncology.
Chou
N
N
Department of Neurosurgery.
Lee
K M
KM
Department of Radiation Oncology.
Ang
B W
BW
Department of Radiology.
Cheng
C L
CL
Department of Pathology, National University Health System, Singapore, Singapore.
Lee
S C
SC
Department of Haematology-Oncology. Electronic address: soo_chin_lee@nuh.com.sg.
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D001859:Bone Neoplasms / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D017273:Goserelin / Q000008:administration & dosage; D046648:Hematoma, Subdural, Intracranial / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects; D000077289:Letrozole; D007970:Leukopenia / Q000139:chemically induced; D009570:Nitriles / Q000008:administration & dosage; D011758:Pyrroles / Q000009:adverse effects; D012886:Skull / Q000473:pathology*; D000077210:Sunitinib; D014230:Triazoles / Q000008:administration & dosage
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007211:Indoles; D009570:Nitriles; D011758:Pyrroles; D014230:Triazoles; D017273:Goserelin; D003841:Deoxycytidine; D000068258:Bevacizumab; D000069287:Capecitabine; D000077289:Letrozole; D005472:Fluorouracil; D000077210:Sunitinib